Trintellix vs Latuda
A side-by-side look at two mental health medications advertised on TV. Informational only — not medical advice.
| US Trintellix | US Latuda | |
|---|---|---|
| Generic name | vortioxetine | lurasidone |
| Drug class | Serotonin Modulator (Antidepressant) | Atypical Antipsychotic |
| Treats | Major depressive disorder | Schizophrenia, bipolar depression |
| Category | Mental Health | Mental Health |
| Manufacturer | Takeda/Lundbeck | Sunovion (Sumitomo) |
| Year approved | 2013 | 2010 |
| FDA warning | Black box warning | Black box warning |
| Est. TV ad spend | $130M | $85M |
| Common side effects | Nausea, Sexual problems, Constipation, Vomiting | Sleepiness, Restlessness, Nausea, Movement problems |
Trintellix
Frequently asked questions
Is Trintellix or Latuda better?
Neither is universally "better." Trintellix (vortioxetine) and Latuda (lurasidone) are both used for mental health, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Trintellix and Latuda?
Trintellix is a Serotonin Modulator (Antidepressant) made by Takeda/Lundbeck, while Latuda is a Atypical Antipsychotic made by Sunovion (Sumitomo). See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Trintellix has the larger estimated TV advertising budget of the two.